Cepheid
↗Sunnyvale, California, USA
Cepheid is a leading molecular diagnostics company dedicated to improving healthcare by developing, manufacturing, and marketing fully integrated systems and tests for genetic testing. The company's GeneXpert System is the world's most popular molecular platform, offering a fully automated way to deliver rapid, actionable diagnostic results.
Cepheid's technology focuses on infectious diseases, oncology, and human genetics. By automating highly complex and time-consuming manual procedures, the company enables institutions of any size to perform sophisticated genetic testing for organisms and genetic diseases. Since its acquisition by Danaher, Cepheid has significantly expanded its global footprint, particularly in point-of-care testing.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Molecular Diagnostics
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$3B-$5B
Founded:1996
Ownership:subsidiary
Status:acquired
FUNDING
Stage:Acquired
Total Raised:$4000M
Investors:Danaher Corporation, T. Rowe Price, Vanguard Group
STOCK
Exchange:NYSE
Ticker:DHR
Market Cap:$185B (Danaher)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:PCR (Polymerase Chain Reaction), Molecular Diagnostics, Nucleic Acid Amplification Test (NAAT)
Active Trials:12
Trial Phases:-
FDA Approvals:35
EMA Approvals:40
CORPORATE STRUCTURE
Parent Company:Danaher Corporation
Acquired By:Danaher Corporation (2016-11-01)
Key Partnerships:FIND (Foundation for Innovative New Diagnostics), World Health Organization (WHO), Bill & Melinda Gates Foundation
COMPETITION
Position:Leader
Competitors:Roche Diagnostics, Abbott Laboratories, Hologic, Qiagen, Bio-Rad, Becton Dickinson (BD)
LEADERSHIP
Key Executives:
Vitor Rocha - President
David H. Persing, M.D., Ph.D. - Chief Medical and Scientific Officer
Scientific Founders:Kurt Petersen, Gregory Kovacs, Bill McMillan
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cepheid. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.